This company has shut down. Sense Biodetection is no longer operating — its last tracked round was a Series B in 2021.
Explore the Startup GraveyardSense Biodetection is a molecular diagnostics company .
Sense Biodetection has raised $15.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Sense Biodetection's investors include Cambridge Innovation Capital, Innovate UK, Earlybird Venture Capital, Mercia Asset Management, Koch Disruptive Technologies.
Sense Biodetection is headquartered in Abingdon, United Kingdom.
Sense Biodetection is a molecular diagnostics company .
Sense Biodetection is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sense Biodetection — Funding & Investors." VCBacked, November 17, 2021, https://www.vcbacked.co/company/sense-biodetection. Accessed August 14, 2026.
VCBacked. (2021). Sense Biodetection — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/sense-biodetection
{{cite web |title=Sense Biodetection — Funding & Investors |url=https://www.vcbacked.co/company/sense-biodetection |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated